Amarin Corp Plc (AMRN)

[DMC8]

AMRN Q1 2026 Earnings Call Transcript

M&A Signal Analysis
M&A Hints from Berg & Team — Strong but Carefully Worded

There are multiple deliberate breadcrumbs suggesting Berg is positioning AMRN for a sale or major strategic transaction, though he’s threading the needle on Reg FD. Here’s what stands out:

1. The Barclays mention — repeated twice, unprompted
Berg referenced the Barclays advisory engagement twice in the call — once in prepared remarks and again in the Q&A. The exact framing is telling: “exploring additional potential pathways to further enhance shareholder value.” Companies don’t keep an investment bank on retainer for 12+ months to do nothing. The fact that Barclays is still engaged this far into 2026 — and that management chose to remind investors of it — is the single strongest signal in the transcript.

2. “We are not in any type of desperate situation… we are being opportunistic”
This is classic sell-side prep language. Translation: we don’t need to sell, but we will if the right bid comes in. Berg is signalling to potential acquirers that AMRN won’t accept a fire-sale price, while simultaneously signalling to shareholders that a transaction is on the table.

3. The “tale of two companies” framing
Berg explicitly described AMRN as two separable assets: a US cash-generating runoff business and a European/RoW growth engine anchored by Recordati. This is exactly how a banker would package the company for a strategic buyer or PE firm — the architecture invites a sum-of-the-parts bid, a full takeout, or a separation/spin.

4. Cash position emphasis
$308M cash, no debt, working capital of $450M, two consecutive quarters of positive cash flow, $70M annualised cost saves locked in. Berg and Fishman repeatedly drew attention to a clean, de-risked balance sheet — exactly what you present when you’re showing the company to bidders or preparing a return-of-capital event.

5. The capital return answer to Paul Choi
Berg’s answer was carefully non-committal but loaded: buybacks/dividends “could possibly happen at the right time,” but the team is “thinking more holistically, strategically about the total value of the company.” That last phrase — “total value of the company” — is M&A vocabulary, not capital allocation vocabulary. He’s saying we’d rather monetise the whole thing than dribble cash back.

6. AG strategy as optionality, not urgency
Berg confirmed they’re “ready to launch” an authorised generic but haven’t pulled the trigger. Keeping the AG in reserve preserves a clean, brand-led P&L that’s easier for an acquirer to model — launching the AG would muddy the picture mid-process.

Net read: The call doesn’t announce anything, but the subtext is consistent with a company that has been quietly running a process. Berg is not promising a deal, but he’s clearly signalling that the strategic review is live and that capital return alone is unlikely to be the answer.

What JPM and Goldman Were Actually Fishing For

Jessica Fye (JPMorgan) — Probing Earnings Quality and Cash Flow Durability
Fye’s questions were not about M&A directly — she was stress-testing the numbers underneath any M&A or valuation case. Her angles:

• “Right way to think about US net price over the rest of the year” — She’s trying to model the slope of US revenue decline. The exclusive PBM contract is the linchpin; if that flips, the cash flow story collapses. She wanted Fishman on the record about NSP trajectory.

• “Sustainability of positive cash flow beyond 2026” — This is the key valuation question. A buyer (or a DCF model) needs to know whether 2026’s cash generation is a one-off (driven by restructuring savings + regained PBM exclusive) or a durable run-rate. Fishman’s answer was conditional (“driven by how we retain those exclusive contracts”) — which is exactly the honest answer, and Fye knew that’s what she’d get.

• Gross margin and SG&A run-rate follow-ups — She’s building a clean post-restructuring P&L model. If you’re an analyst trying to value AMRN either standalone or as a takeout target, you need the steady-state cost structure nailed down. Q1 2026 is the first relatively clean quarter to anchor that model.

Bottom line on Fye: She was building the financial baseline. Every sell-side analyst covering AMRN right now needs a defensible 2026/2027 cash flow model because that’s what any takeout premium will be measured against.

Paul Choi (Goldman Sachs) — Directly Probing for the M&A / Capital Return Catalyst
Choi’s two questions were sharper and more strategic:

• Physician feedback on the new ACC/AHA guidelines — On the surface this is a commercial question, but it’s really a terminal value question. If guideline inclusion meaningfully extends the demand curve for icosapent ethyl, the European Recordati royalty stream becomes far more valuable, and so does AMRN as an acquisition target. Choi was checking whether the guideline update changes the strategic calculus. Berg’s answer was honest: positive qualitatively, too early to quantify.

• Returning cash to shareholders — This was the direct M&A fishing question, just phrased politely. Choi essentially asked: “You’re now cash flow positive, the stock is depressed, you have $308M sitting there — what are you going to do with it?” He gave Berg three implicit options: buyback, dividend, or “another form” (i.e., a transaction). Berg’s response — declining to commit to capital return and pivoting to “total value of the company” and the Barclays process — was the most M&A-suggestive moment of the call. Choi got exactly the signal he was looking for.

Bottom line on Choi: He was explicitly trying to extract a catalyst — either a capital return announcement or confirmation that a strategic process is active. He got the latter, in coded form.

Summary
Fye was modelling the floor (durable cash flow). Choi was probing the ceiling (strategic catalyst). Berg confirmed the floor is real and hinted — without committing — that the ceiling involves something more than a buyback. For an AMRN holder, the most actionable signal in this transcript is the continued Barclays engagement combined with Berg’s “total value of the company” framing in response to a direct capital-return question. That’s not a guarantee of a sale, but it’s the clearest tell yet that management’s preferred exit is a transaction rather than an ongoing standalone runoff.